Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P V Datsenko

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Zhurnal Voprosy Neirokhirurgii Imeni N. N. Burdenko|October 13, 2023
[Extent of resection in patients with glioblastoma]T M Kobyletskaya, A S Chuguev, A M Zaytsev, et al.
Voprosy Onkologii|December 16, 2006
[Five-year outcome of a new combination chemotherapy with CEA/ABVD for advanced Hodgkin's disease with poor prognosis]V P Kharchenko, P V Datsenko, G A Panyshin, et al.
Voprosy Onkologii|October 14, 2006
[Novel approaches to combination therapy of Hodgkin's disease]V P Kharchenko, G A Pan'shin, P V Datsenko, et al.
Voprosy Onkologii|December 9, 2010
[Risk factors for hematologic toxicity and multifaceted analysis of blood in Hodgkin's disease: a model for hematologic toxicity]P V Datsenko, P N Podol'skiĭ, G A Pan'shin, et al.
Voprosy Onkologii|December 2, 2009
[The role of adjuvant radiotherapy in the complex treatment of stage III-IV aggressive non-Hodgkin's lymphoma]V M Sotnikov, G A Pan'shin, P V Datsenko, et al.
Terapevticheskii Arkhiv|January 1, 1991
[Risk factors and survival prognosis in lymphogranulomatosis: a statistical analysis]G A Pan'shin, V M Sotnikov, P V Datsenko, et al.
Zhurnal Voprosy Neirokhirurgii Imeni N. N. Burdenko|October 29, 2021
[Superselective intra-arterial administration of bevacizumab with blood-brain barrier disruption in patients with recurrent malignant gliomas: case report and literature review]A D Kaprin, A M Zaitsev, A G Rerberg, et al.
Zhurnal Voprosy Neirokhirurgii Imeni N. N. Burdenko|June 16, 2023
[Early progression of glioblastoma before radiotherapy]P V Datsenko, T M Kobyletskaya, A S Chuguev, et al.
Zhurnal Voprosy Neirokhirurgii Imeni N. N. Burdenko|October 18, 2024
[Choice of fractionation regimen for Grade IV gliomas depending on rapid early progression]A S Chuguev, T M Kobyletskaya, V A Gerasimov, et al.
Voprosy Onkologii|December 2, 2009
[Multivariate analysis of risk of cardiac complications in Hodgkin's lymphoma]P N Podol'skiĭ, P V Datsenko, G A Pan'shin, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Zhurnal Voprosy Neirokhirurgii Imeni N. N. Burdenko|October 13, 2023
[Extent of resection in patients with glioblastoma]T M Kobyletskaya, A S Chuguev, A M Zaytsev, et al.
Voprosy Onkologii|December 16, 2006
[Five-year outcome of a new combination chemotherapy with CEA/ABVD for advanced Hodgkin's disease with poor prognosis]V P Kharchenko, P V Datsenko, G A Panyshin, et al.
Voprosy Onkologii|October 14, 2006
[Novel approaches to combination therapy of Hodgkin's disease]V P Kharchenko, G A Pan'shin, P V Datsenko, et al.
Voprosy Onkologii|December 9, 2010
[Risk factors for hematologic toxicity and multifaceted analysis of blood in Hodgkin's disease: a model for hematologic toxicity]P V Datsenko, P N Podol'skiĭ, G A Pan'shin, et al.
Voprosy Onkologii|December 2, 2009
[The role of adjuvant radiotherapy in the complex treatment of stage III-IV aggressive non-Hodgkin's lymphoma]V M Sotnikov, G A Pan'shin, P V Datsenko, et al.
Terapevticheskii Arkhiv|January 1, 1991
[Risk factors and survival prognosis in lymphogranulomatosis: a statistical analysis]G A Pan'shin, V M Sotnikov, P V Datsenko, et al.
Zhurnal Voprosy Neirokhirurgii Imeni N. N. Burdenko|October 29, 2021
[Superselective intra-arterial administration of bevacizumab with blood-brain barrier disruption in patients with recurrent malignant gliomas: case report and literature review]A D Kaprin, A M Zaitsev, A G Rerberg, et al.
Zhurnal Voprosy Neirokhirurgii Imeni N. N. Burdenko|June 16, 2023
[Early progression of glioblastoma before radiotherapy]P V Datsenko, T M Kobyletskaya, A S Chuguev, et al.
Zhurnal Voprosy Neirokhirurgii Imeni N. N. Burdenko|October 18, 2024
[Choice of fractionation regimen for Grade IV gliomas depending on rapid early progression]A S Chuguev, T M Kobyletskaya, V A Gerasimov, et al.
Voprosy Onkologii|December 2, 2009
[Multivariate analysis of risk of cardiac complications in Hodgkin's lymphoma]P N Podol'skiĭ, P V Datsenko, G A Pan'shin, et al.
Pageof 3